Catalent Pharma Solutions Brasil company information, Employees & Contact Information

Catalent Debuts New Corporate Brand, Elevating Customer Service Excellence by “Championing the Missions that Matter™” The AI Journal

Catalent's Award-Winning Innovations and Community Engagement Initiatives Pharmaceutical Technology

Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research GlobeNewswire

Catalent Announces Opening of its New Global Corporate Headquarters in Tampa, Florida Yahoo Finance

Catalent Announces New Board Appointments Business Wire

Novo Holdings Completes Acquisition of Catalent citybiz

Jupiter Neurosciences Announces JOTROL Manufacturing Agreement with Catalent to Support Phase 2a Parkinson’s Trial Yahoo Finance

Catalent to Lay Off 350 Workers at Baltimore Gene Therapy Plant Pharmaceutical Commerce

Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement PR Newswire

Pace Life Sciences Expands Capacity and Capability With Acquisition of Catalent’s Analytical Services Laboratory in Research Triangle Park Newswire.com

Compatibility Assessment of a Model Monoclonal Antibody Formulation in Glass and Blow–Fill–Seal Plastic Vials BioProcess International

Novo Holdings To Acquire CDMO Catalent Pharma Solutions For $16.5 Billion Pharmaceutical Online

Catalent, Inc. Reports First Quarter Fiscal 2025 Results Business Wire

Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany Business Wire

Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility Business Wire

Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results Business Wire

Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings Business Wire

Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader Business Wire

Catalent Completes $5.5M Phased Clinical Storage Expansion At Kansas City Campus Clinical Leader

Catalent, Inc. Reports Third Quarter Fiscal 2024 Results Business Wire

Catalent, Inc. Reports Second Quarter Fiscal 2024 Results Business Wire

Catalent Appoints Sridhar Krishnan to Lead New Global Operational Excellence Strategy, “The Catalent Way” Business Wire

Catalent, Inc. Reports Second Quarter Fiscal 2023 Results Business Wire

Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement GlobeNewswire

Catalent Appoints Lisa Evoli as Senior Vice President and Chief Human Resources Officer citybiz

Cybin Signs Drug Development Agreement with Catalent for its Fast-Dissolve Formulation of Novel, Deuterated Tryptamine (CYB003) Psychedelic Alpha

Catalent Appoints Joseph A. Ferraro as Senior Vice President citybiz

Catalent Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022 Business Wire

Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline Business Wire

Catalent to Acquire RheinCell in Effort to Industrialize iPSC Therapies BioInformant

Catalent Announces Changes to its Board of Directors Business Wire

Catalent Biologics Supports an Ever-Evolving Bioindustry Genetic Engineering and Biotechnology News

Catalent Promotes Thomas Castellano to CFO citybiz

Catalent's Flexible Fill/Finish Capabilities for Drug Products BioPharm International

$10M+ Milestones: Lisata Licenses Certepetide to Catalent for SMARTag® ADC Development Stock Titan

Perrigo and Catalent Announce FDA Approval of Perrigo's AB-rated Generic Version of ProAir® HFA Perrigo

Novo Nordisk Acquire Catalent for $16.5 Billion, Enhancing Obesity Drugs Production Capacity geneonline.com

Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine GlobeNewswire

Bioprocessing Technologies—Then and Now Genetic Engineering and Biotechnology News

Catalent's Chair and CEO, John Chiminski, to Speak About R&D Leadership Through the Pandemic During BIO Digital PRWeb

PRESS RELEASE SEC.gov

Catalent, Inc. to Present at June Investor Conferences FinancialContent

Paragon announces its second GMP manufacturing facility and the expansion of its strategic collaboration in manufacturing design and operation with gene therapy leader Sarepta Therapeutics PR Newswire

Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash PR Newswire

Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment | Fat Pitch Financials FinancialContent

Catalent is laying off 400 employees according to a message sent to workers in Bloomington, Indiana The Bloomingtonian

Catalent Announces Governance Enhancements and New Initiatives to Drive Value FinancialContent

Catalent Appoints Dr. Guy Dewil as General Manager of its Clinical Supply Facility in Schorndorf, Germany PRWeb

Catalent, Inc. Announces Third Quarter Fiscal Year 2022 Earnings Conference Webcast FinancialContent

Catalent Adds New Cryogenic Capabilities at Shiga, Japan, Facility to Support Clinical Supply Demand for Cell and Gene Therapy Development - PR Newswire APAC 美通社

Catalent Appoints Manja Boerman President citybuzz -

Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions PR Newswire

Catalent Biologics and Triphase Accelerator Corporation GlobeNewswire

Catalent Applied Drug Delivery Institute Welcomes Accomplished Life Sciences Leader Dr. Ralph Lipp to Advisory Board and Terry Robinson as Executive Director Anadolu Ajansı